Global Nuclear Medicine Diagnostics Market Key Players Competitive Survey Report 2023

Report ID: ARS10988 | Category: Healthcare | Pages: 107 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3650.00 Multi User-$6200.00

Report Description
View Table of Contents

Report Summary

The global Nuclear Medicine Diagnostics market size in 2022 is 6525.5 million US dollars, and it is expected to be 13210.0 million US dollars by 2029, with a compound annual growth rate of 10.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Nuclear Medicine Diagnostics market include Cardinal Health (U.S.), General Electric (U.S.), Lantheus (U.S.), Bayer AG (Germany), and Bracco Diagnostic Inc. (Italy). The share of the top 3 players in the Nuclear Medicine Diagnostics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Nuclear Medicine Diagnostics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. SPECT Radiopharmaceuticals accounted for XX% of Nuclear Medicine Diagnostics market in 2022. PET Radiopharmaceuticals share of XX%.
Hospitals and diagnostic centers accounted for XX% of the Nuclear Medicine Diagnostics market in 2022. Research Institutes accounts for XX%.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Nuclear Medicine Diagnostics market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.

The report analyzes the key trends in each segment of the global Nuclear Medicine Diagnostics market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.

Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Nuclear Medicine Diagnostics market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Nuclear Medicine Diagnostics market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Nuclear Medicine Diagnostics industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.

Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.
Chapters 2-4: Segmented the global Nuclear Medicine Diagnostics market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Nuclear Medicine Diagnostics market type, application and country market segmentation data.
Chapter 10: Analysis of the competitive environment of Nuclear Medicine Diagnostics market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapter 11: Analyzes the main companies in the Nuclear Medicine Diagnostics industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 12-14: Provide detailed Nuclear Medicine Diagnostics market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
Cardinal Health (U.S.)
General Electric (U.S.)
Lantheus (U.S.)
Bayer AG (Germany)
Bracco Diagnostic Inc. (Italy)
NorthStar Medical Radioisotopes, LLC (U.S.)
Eckert & Ziegler. (Germany)
Jubilant DraxImage, Inc. (Canada)
PharmaLogic Holdings Corp. (U.S.)
Institute of Isotopes Co., Ltd (Hungary)
SHINE Medical Technologies, LLC (U.S.)
Global Medical Solutions LLC (China)

Types list
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals

Application list
Hospitals and diagnostic centers
Research Institutes

Table of Content

1 Nuclear Medicine Diagnostics Market Introduction and Overview
1.1 Nuclear Medicine Diagnostics Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Nuclear Medicine Diagnostics Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Nuclear Medicine Diagnostics Revenue and Market Share by Type
3 Global Nuclear Medicine Diagnostics Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Nuclear Medicine Diagnostics Revenue Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Nuclear Medicine Diagnostics Market Size (2018-2023)
4.2 Nuclear Medicine Diagnostics Growth Trends Analysis by Regions
4.2.1 Nuclear Medicine Diagnostics Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Nuclear Medicine Diagnostics Historic Revenue Market Size by Regions (2018-2023)
4.2.3 North America Nuclear Medicine Diagnostics Market Size (2018-2023)
4.2.4 Europe Nuclear Medicine Diagnostics Market Size (2018-2023)
4.2.5 Asia-Pacific Nuclear Medicine Diagnostics Market Size (2018-2023)
4.2.6 Latin America Nuclear Medicine Diagnostics Market Size (2018-2023)
4.2.7 Middle East & Africa Nuclear Medicine Diagnostics Market Size (2018-2023)
5 North America
5.1 North America Nuclear Medicine Diagnostics Revenue by Countries
5.1.1 North America Nuclear Medicine Diagnostics Revenue by Countries (2018-2023)
5.2 North America Nuclear Medicine Diagnostics Revenue by Types
5.3 North America Nuclear Medicine Diagnostics Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Nuclear Medicine Diagnostics Revenue by Countries
6.1.1 Asia Pacific Nuclear Medicine Diagnostics Revenue by Countries (2018-2023)
6.2 Asia Pacific Nuclear Medicine Diagnostics Revenue by Types
6.3 Asia Pacific Nuclear Medicine Diagnostics Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nuclear Medicine Diagnostics Revenue by Countries
7.1.1 Europe Nuclear Medicine Diagnostics Revenue by Countries (2018-2023)
7.2 Europe Nuclear Medicine Diagnostics Revenue by Types
7.3 Europe Nuclear Medicine Diagnostics Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Nuclear Medicine Diagnostics Revenue by Countries
8.1.1 Latin America Nuclear Medicine Diagnostics Revenue by Countries (2018-2023)
8.2 Latin America Nuclear Medicine Diagnostics Revenue by Types
8.3 Latin America Nuclear Medicine Diagnostics Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Nuclear Medicine Diagnostics Revenue by Countries
9.1.1 Middle East & Africa Nuclear Medicine Diagnostics Revenue by Countries (2018-2023)
9.2 Middle East & Africa Nuclear Medicine Diagnostics Revenue by Types
9.3 Middle East & Africa Nuclear Medicine Diagnostics Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Nuclear Medicine Diagnostics Market Competition, by Players
10.1 Global Nuclear Medicine Diagnostics Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Nuclear Medicine Diagnostics Players Market Share in 2022
10.2.2 Top 6 Nuclear Medicine Diagnostics Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Nuclear Medicine Diagnostics Players Head Office, Business Provided
10.4 Nuclear Medicine Diagnostics Mergers & Acquisitions
10.5 Nuclear Medicine Diagnostics New Entrants and Expansion Plans
11 Players Profiles11.1 Cardinal Health (U.S.)
11.1.1 Cardinal Health (U.S.) Company Profile
11.1.2 Nuclear Medicine Diagnostics Product Overview
11.1.3 Cardinal Health (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.1.4 Cardinal Health (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 General Electric (U.S.)
11.2.1 General Electric (U.S.) Company Profile
11.2.2 Nuclear Medicine Diagnostics Product Overview
11.2.3 General Electric (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.2.4 General Electric (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 Lantheus (U.S.)
11.3.1 Lantheus (U.S.) Company Profile
11.3.2 Nuclear Medicine Diagnostics Product Overview
11.3.3 Lantheus (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.3.4 Lantheus (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Bayer AG (Germany)
11.4.1 Bayer AG (Germany) Company Profile
11.4.2 Nuclear Medicine Diagnostics Product Overview
11.4.3 Bayer AG (Germany) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.4.4 Bayer AG (Germany) Business Overview
11.4.5 Recent Developments and Plans
11.5 Bracco Diagnostic Inc. (Italy)
11.5.1 Bracco Diagnostic Inc. (Italy) Company Profile
11.5.2 Nuclear Medicine Diagnostics Product Overview
11.5.3 Bracco Diagnostic Inc. (Italy) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.5.4 Bracco Diagnostic Inc. (Italy) Business Overview
11.5.5 Recent Developments and Plans
11.6 NorthStar Medical Radioisotopes, LLC (U.S.)
11.6.1 NorthStar Medical Radioisotopes, LLC (U.S.) Company Profile
11.6.2 Nuclear Medicine Diagnostics Product Overview
11.6.3 NorthStar Medical Radioisotopes, LLC (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.6.4 NorthStar Medical Radioisotopes, LLC (U.S.) Business Overview
11.6.5 Recent Developments and Plans
11.7 Eckert & Ziegler. (Germany)
11.7.1 Eckert & Ziegler. (Germany) Company Profile
11.7.2 Nuclear Medicine Diagnostics Product Overview
11.7.3 Eckert & Ziegler. (Germany) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.7.4 Eckert & Ziegler. (Germany) Business Overview
11.7.5 Recent Developments and Plans
11.8 Jubilant DraxImage, Inc. (Canada)
11.8.1 Jubilant DraxImage, Inc. (Canada) Company Profile
11.8.2 Nuclear Medicine Diagnostics Product Overview
11.8.3 Jubilant DraxImage, Inc. (Canada) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.8.4 Jubilant DraxImage, Inc. (Canada) Business Overview
11.8.5 Recent Developments and Plans
11.9 PharmaLogic Holdings Corp. (U.S.)
11.9.1 PharmaLogic Holdings Corp. (U.S.) Company Profile
11.9.2 Nuclear Medicine Diagnostics Product Overview
11.9.3 PharmaLogic Holdings Corp. (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.9.4 PharmaLogic Holdings Corp. (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Institute of Isotopes Co., Ltd (Hungary)
11.10.1 Institute of Isotopes Co., Ltd (Hungary) Company Profile
11.10.2 Nuclear Medicine Diagnostics Product Overview
11.10.3 Institute of Isotopes Co., Ltd (Hungary) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.10.4 Institute of Isotopes Co., Ltd (Hungary) Business Overview
11.10.5 Recent Developments and Plans
11.11 SHINE Medical Technologies, LLC (U.S.)
11.11.1 SHINE Medical Technologies, LLC (U.S.) Company Profile
11.11.2 Nuclear Medicine Diagnostics Product Overview
11.11.3 SHINE Medical Technologies, LLC (U.S.) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.11.4 SHINE Medical Technologies, LLC (U.S.) Business Overview
11.11.5 Recent Developments and Plans
11.12 Global Medical Solutions LLC (China)
11.12.1 Global Medical Solutions LLC (China) Company Profile
11.12.2 Nuclear Medicine Diagnostics Product Overview
11.12.3 Global Medical Solutions LLC (China) Nuclear Medicine Diagnostics Market Performance (2018-2023)
11.12.4 Global Medical Solutions LLC (China) Business Overview
11.12.5 Recent Developments and Plans
12 Global Nuclear Medicine Diagnostics Forecast Market Analysis by Type
12.1 Global Nuclear Medicine Diagnostics Revenue Market Forecast by Type (2023-2029)
13 Global Nuclear Medicine Diagnostics Forecast Market Analysis by Application
13.1 Nuclear Medicine Diagnostics Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Nuclear Medicine Diagnostics Forecast Market Size (2023-2029)
14.2 Nuclear Medicine Diagnostics Growth Trends Forecast Analysis by Regions
14.2.1 Nuclear Medicine Diagnostics Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Nuclear Medicine Diagnostics Forecast Market Size (2023-2029)
14.2.3 Europe Nuclear Medicine Diagnostics Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Nuclear Medicine Diagnostics Forecast Market Size (2023-2029)
14.2.5 Latin America Nuclear Medicine Diagnostics Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Nuclear Medicine Diagnostics Forecast Market Size (2023-2029)
15 Nuclear Medicine Diagnostics Industry Dynamic Analysis
15.1 Nuclear Medicine Diagnostics Market Trends Analysis
15.2 Nuclear Medicine Diagnostics Market Drivers Analysis
15.3 Nuclear Medicine Diagnostics Market Challenges Analysis
15.4 Nuclear Medicine Diagnostics Market Restraints Analysis

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Nuclear Medicine Diagnostics Market Key Players Competitive Survey Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?